Dr. Julie Louise Gerberding became the first woman Director of the U.S. Centers for Disease Control and Prevention
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the U.S….
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
University of Minnesota researchers Povide Evidence That Adults Stem Cells Differentiate Like Embryonic Stem Cells
On Jun. 24, 2002, researchers at the University of Minnesota Stem Cell Institute (SCI) announced they had found…
Diagnostics | Infectious Disease | Polio | Vaccine | WHO
The European Region was certified polio-free
On Jun. 21, 2002, all 53 Member States in the World Health Organization (WHO) European Region were certified…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
NCI scientists identified adult patients with non-Hodgkin’s lymphoma likely to be cured by chemotherapy
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
Biotechnology | Diagnostics | FDA | Infectious Disease | Medicine | NIH | Plague | Radiology | Therapeutics | U.S. Congress
President Bush signed the Public Health Security and Bioterrorism Preparedness and Response Act into law
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
The Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research Institute
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
The Translational Genomics Research Institute (TGen) was founded
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
NCI researchers reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress
The Hematologic Cancer Research Investment and Education Act Signed into Law
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
The International Genomics Consortium selected Phoenix for its headquarters
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
Quinton Cardiology launched its IPO
On May 7, 2002, Quinton Cardiology Systems held its Initial Public Offering raising $28 million. The Bothell, Washington…
Governor Hull signed SB 1270 that provided $5 million over 10 years for genomic research
In May 2002, Governor Hull signed SB 1270 for $5 million over 10 years for genomic research. Later…
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
The FDA approved the first nucleic acid test system to screen whole blood donors for infections with HIV and HCV
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Pioneer Hi-Bred International endowed Maize Breeding Chair at Iowa State University
On Feb. 12, 2002, Pioneer Hi-Bred International made a gift to endow a faculty chair in maize breeding…
Emory University established the Tobacco Technical Assistance Consortium
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
Scientists from NCI and FDA reported that patterns of proteins found in patients’ serum may reflect the presence of ovarian cancer
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
The Translational Genomics Research Institute (TGen) was envisioned
On Feb. 7, 2002, an assembly of more than fifty leaders and visionaries in science, medicine, government and…
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
Cook County Hospital opened doors to John Stroger Hospital of Cook County
In February 2002, the doors opened to the John Stroger Hospital of Cook County, a new state-of-the-art, 464-bed,…
Andrew C von Eschenbach became the twelfth director of the National Cancer Institute, serving until 2006
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
ZymoGenetics announced its Initial Public Offering
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
President George W Bush signed PL 107-109 – S 1789, the Best Pharmaceuticals for Children Act
On Jan. 4, 2002, President George W. Bush signed P.L. 107-109 – S. 1789, the Best Pharmaceuticals for…
The Best Pharmaceuticals for Children Act was signed into law
On Jan. 4, 2002, The Best Pharmaceuticals for Children Act was signed into law, established a process for…
Virginia Commonwealth University and INOVA Fairfax partnered to establish medical program in Northern Virginia
In 2002, the Virginia Commonwealth University (VCU) and INOVA Fairfax partnered to establish a medical program in Northern…
Gateway Building opened at Virginia Commonwealth University Medical Center
In 2002, The Gateway Building opened at VCU Medical Center, a $39 million dollar structure, opened in March…
Pacific Northwest Research Institute led consortium that conducted first human islet transplantation in Puget Sound region
On Jul. 30, 2002, Dr. R. Paul Robertson, President and Scientific Director at the Pacific Northwest Research Foundation…